Appropriate Selection of Substrate Ablation for Persistent Atrial Fibrillation Using Intraprocedural Assessment

• Published in: Circulation Journal Vol. 88; no. 7; pp. 1068 - 1077
• Main Authors: Matsunaga-Lee, Yasuharu, Inoue, Koichi, Tanaka, Nobuaki, Masuda, Masaharu, Watanabe, Tetsuya, Makino, Nobuhiko, Egami, Yasuyuki, Oka, Takafumi, Minamiguchi, Hitoshi, Miyoshi, Miwa, Okada, Masato, Kanda, Takashi, Matsuda, Yasuhiro, Kawasaki, Masato, Kawanami, Shodai, Sugae, Hiroki, Ukita, Kohei, Kawamura, Akito, Yasumoto, Koji, Tsuda, Masaki, Okamoto, Naotaka, Yano, Masamichi, Nishino, Masami, Sunaga, Akihiro, Sotomi, Yohei, Dohi, Tomoharu, Nakatani, Daisaku, Hikoso, Shungo, Sakata, Yasushi, on behalf of the Osaka Cardiovascular Conference (OCVC) Arrhythmia Investigators
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Circulation Society 25.06.2024
• Subjects: Ablation; Aged; Atrial Fibrillation - physiopathology; Atrial Fibrillation - surgery; Catheter Ablation - methods; Female; Heart Rate; Humans; Male; Middle Aged; Patient Selection; Persistent atrial fibrillation; Prospective Studies; Pulmonary Veins - physiopathology; Pulmonary Veins - surgery; Recurrence; Selection; Substrate ablation; Treatment Outcome; Trigger; Trigger; Ablation; Substrate ablation; Selection; Persistent atrial fibrillation
• ISSN: 1346-9843; 1347-4820; 1347-4820
• DOI: 10.1253/circj.CJ-23-0936

Background: It has not been fully elucidated which patients with persistent atrial fibrillation (PerAF) should undergo substrate ablation plus pulmonary vein isolation (PVI). This study aimed to identify PerAF patients who required substrate ablation using intraprocedural assessment of the baseline rhythm and the origin of atrial fibrillation (AF) triggers.Methods and Results: This was a post hoc subanalysis using extended data of the EARNEST-PVI trial, a prospective multicenter randomized trial comparing PVI-alone and PVI-plus (i.e., PVI with added catheter ablation) arms. We divided 492 patients into 4 groups according to baseline rhythm and the location of AF triggers before PVI: Group A (n=22), sinus rhythm with pulmonary vein (PV)-specific AF triggers (defined as reproducible AF initiation from PVs only); Group B (n=211), AF with PV-specific AF triggers; Group C (n=94), sinus rhythm with no PV-specific AF trigger; Group D (n=165), AF with no PV-specific AF trigger. Among the 4 groups, only in Group D (AF at baseline and no PV-specific AF triggers) was arrhythmia-free survival significantly lower in the PVI-alone than PVI-plus arm (P=0.032; hazard ratio 1.68; 95% confidence interval 1.04–2.70).Conclusions: Patients with sinus rhythm or PV-specific AF triggers did not receive any benefit from substrate ablation, whereas patients with AF and no PV-specific AF trigger benefited from substrate ablation.